Literature DB >> 8811676

Intracranial metastases of hepatocellular carcinoma: CT and MRI.

K Murakami1, S Nawano, N Moriyama, R Sekiguchi, M Satake, H Fujimoto, T Ichikawa.   

Abstract

We report clinical characteristics and CT and MRI in 16 patients with brain metastases due to hepatocellular carcinoma (HCC). Eight of these 16 patients presented with apoplexy-like symptoms (50%). Pulmonary metastases were found in 13 cases (81.3%). The mean survival from the appearance of cerebral metastases to death was 6.2 weeks, which is one of the shortest survival terms in metastatic brain tumours. Haemorrhagic brain metastases were observed in 14 patients (87.5%) with a tendency for the frequency of bleeding to increase in proportion to the size of the tumour. On both contrast-enhanced CT and MRI, metastatic brain tumours enhanced strongly, suggesting that brain metastases, like HCC, are also hypervascular. MRI is useful in evaluating brain metastases from HCC, especially in order to differentiate tumour from haemorrhage. Our results demonstrated a poor prognosis and bleeding tendency of brain metastases due to HCC and showed the usefulness of CT and MRI in achieving a correct diagnosis.

Entities:  

Mesh:

Year:  1996        PMID: 8811676     DOI: 10.1007/bf02278115

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  Spontaneous intracerebral hematoma caused by cerebral neoplasms. Report of eight verified cases.

Authors:  M Scott
Journal:  J Neurosurg       Date:  1975-03       Impact factor: 5.115

2.  Craniospinal and cerebral metastasis of primary hepatomas: a report of 7 cases.

Authors:  Y C Chang; R C Chen
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1979-06

3.  Solitary pontine metastasis from hepatocellular carcinoma: a case report.

Authors:  A Uchino; T Miyoshi; M Ohno
Journal:  Radiat Med       Date:  1987 Jul-Aug

4.  Brain metastasis of hepatocellular carcinoma presenting with hemorrhage--case report.

Authors:  S Otsuka; T Fukumitsu; T Yamamoto; H Komori; H Shirane
Journal:  Neurol Med Chir (Tokyo)       Date:  1987-07       Impact factor: 1.742

5.  Increased detection of intracranial metastases with intravenous Gd-DTPA.

Authors:  M E Healy; J R Hesselink; G A Press; M S Middleton
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

6.  Intracranial metastasis of hepatic carcinomas: a study of 9 cases within 28 years.

Authors:  S Shuangshoti; S Rungruxsirivorn; R Panyathanya
Journal:  J Med Assoc Thai       Date:  1989-06

7.  Cerebral hemorrhage from unsuspected choriocarcinoma.

Authors:  E M van den Doel; F J van Merriënboer; C A Tulleken
Journal:  Clin Neurol Neurosurg       Date:  1985       Impact factor: 1.876

8.  Hemorrhagic metastatic intracranial neoplasms: clinical-computed tomographic correlations.

Authors:  L A Weisberg
Journal:  Comput Radiol       Date:  1985 Mar-Apr

9.  Hepatocellular carcinoma presenting as intracranial metastasis.

Authors:  J P Lee; S T Lee
Journal:  Surg Neurol       Date:  1988-10

10.  Metastic tumor presenting as intracerebral hemorrhage. Report of 6 cases examined by computed tomography.

Authors:  N Gildersleeve; A H Koo; C J McDonald
Journal:  Radiology       Date:  1977-07       Impact factor: 11.105

View more
  19 in total

1.  Little response of cerebral metastasis from hepatocellular carcinoma to any treatments.

Authors:  Jung Ho Han; Dong Gyu Kim; Jung Cheol Park; Hyun-Tai Chung; Sun Ha Paek; Young Seob Chung
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

2.  Increasing incidence of brain metastasis in patients with advanced hepatocellular carcinoma in the era of antiangiogenic targeted therapy.

Authors:  Yu-Yun Shao; Li-Chun Lu; Ann-Lii Cheng; Chih-Hung Hsu
Journal:  Oncologist       Date:  2011-01-06

3.  Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma.

Authors:  Seungtaek Lim; Soohyeon Lee; Jae Yun Lim; Ji Soo Park; Jin Sil Seong; Won Seok Chang; Kwang-Hyub Han; Hye Jin Choi
Journal:  J Neurooncol       Date:  2014-07-26       Impact factor: 4.130

4.  Incidence of seizure in adult patients with intracranial metastatic disease.

Authors:  Vivien Chan; Arjun Sahgal; Peter Egeto; Tom Schweizer; Sunit Das
Journal:  J Neurooncol       Date:  2016-11-22       Impact factor: 4.130

Review 5.  Modern management of rare brain metastases in adults.

Authors:  Matthias J Krammer; Andre Tomasino; David B Schul; Sabrina T Astner; Michael P Meier; Christianto B Lumenta
Journal:  J Neurooncol       Date:  2011-06-21       Impact factor: 4.130

6.  Brain metastases from hepatocellular carcinoma in US patients.

Authors:  Joshua Seinfeld; Aaron Scott Wagner; B K Kleinschmidt-DeMasters
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

7.  Radiotherapy for multiple brain metastases from hepatocellular carcinomas.

Authors:  Nobuyuki Toshikuni; Kazuhiko Morii; Michinori Yamamoto
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

8.  Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC.

Authors:  Hye Jin Choi; Byung Chul Cho; Joo Hyuk Sohn; Sang Jun Shin; Se Hyun Kim; Joo Hang Kim; Nae Choon Yoo
Journal:  J Neurooncol       Date:  2008-10-23       Impact factor: 4.130

9.  Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study.

Authors:  Younghee Park; Kyung Su Kim; Kyubo Kim; Eui Kyu Chie; Jin Ho Kim; Jae-Sung Kim; Tae Hyun Kim; Dae Yong Kim; Won Il Jang; Mi-Sook Kim; Tae Ryool Koo; Ah Ram Chang
Journal:  J Neurooncol       Date:  2015-09-05       Impact factor: 4.130

10.  Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors.

Authors:  Xiao-Bing Jiang; Chao Ke; Guan-Hua Zhang; Xiang-Heng Zhang; Ke Sai; Zhong-Ping Chen; Yong-Gao Mou
Journal:  BMC Cancer       Date:  2012-02-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.